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Summary An investigation has been made into the ability of neoplastic B lymphocytes obtained from
lymphoid tissue of patients with non-Hodgkin's lymphoma (NHL) to secrete immunoglobulin (Ig) in vitro.
The majority of the cell populations secreted IgM (17/24 patients), identified as pentameric in three cases
examined, and free monotypic light chains (23/24 patients) of the same type as the surface Ig. Secretion of
IgD (6/21 patients) and IgG (3/21 patients) was found less frequently.
The amounts of Ig secreted were variable and there was no significant difference in the patterns of secretion
of cells from NHL patients when compared to previous studies of chronic lymphocytic leukaemia (CLL), nor
was there any clear correlation with the histological type.
For four of the patients, anti-idiotypic antibody was produced and was used to demonstrate the idiotypic
nature of the secreted Ig, and also to show its presence in the serum. The level of idiotypic IgM was measured
in one patient during chemotherapy and appeared to correlate well with disease.
Such idiotypic Ig must be taken into account when planning treatment of B cell neoplasms with anti-
idiotypic antibody since it could act as a block to antibody attack. Assessment of the ability of tumour cells
to secrete Ig in vitro provides a useful preliminary screen when choosing such patients since a high secretion
rate together with extensive disease could lead to unacceptable levels of serum idiotypic Ig.
Although B lymphocytes are often regarded as non-
secreting cells, it has been shown recently that
populations of neoplastic B lymphocytes do secrete
small amounts of immunoglobulin (Ig) when
cultured in vitro and that such Ig products can be
found in the serum of patients (Stevenson et al.,
1980). Analysis of the secretory capacity of
neoplastic B lymphocytes is useful for several
reasons. First, since the tumour cells may be
"frozen" at a particular stage of B cell
differentiation (Salmon & Seligmann, 1974; Lukes
& Collins, 1974) the ability of such cells to express
and secrete Ig might tell us something about the
normal function of such cells. Second, if anti-
idiotypic antibody is to be used for therapy of such
tumours (Hamblin et al., 1980; Miller et al., 1982)
it is essential to know if such antibody will face an
extracellular barrier of idiotypic Ig. In relation to
this, the measurement of levels of idiotypic Ig in the
patient's plasma could provide a useful marker of
disease load.
Studies of such secretion have been carried out
with neoplastic B lymphocytes from patients with
chronic lymphocytic leukaemia (CLL) (Stevenson et
al., 1980) where it is relatively easy to obtain
monotypic tumour cells from peripheral blood.
Such cell populations when cultured in.vitro have
been shown to export monotypic light chains (19/19
cases studied), small amounts of pentameric IgM
(13/19) and monomeric IgD (8/19) with all those
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exporting IgD being of the A light chain type
(Stevenson et al., 1982). For three of the cases,
anti-idiotypic antibody was used to demonstrate the
idiotypic nature of the exported Ig and for these
patients it was shown that the low level of export
led to an accumulation of idiotypic Ig in the
plasma.
However, in order to broaden the assessment of
B cell behaviour, and since the major therapeutic
potential for anti-idiotype might be in the
lymphomas, we have now extended our
investigations to lymph node biopsy material from
patients with B cell lymphomas. Results on 24
biopsies selected on the basis of heavy involvement
with monotypic tumour cells have shown that the
secretory patterns in non-Hodgkin's lymphoma
(NHL) are similar to those in CLL with the
majority (17/24) of the neoplastic populations
secreting IgM and (23/24) free light chain. For four
patients, the clonal origin of the secreted Ig has
been demonstrated by the use of anti-idiotypic
antibodies.
Materials and methods
Patients and cellpreparations
Patients with known or suspected B cell neoplasms
but with no monoclonal Ig detectable on routine
serum electrophoresis, except one patient studied
for comparative data, were admitted to hospital for
surgical lymph node biopsy. All the patients except
for four were untreated, with the lymph node
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biopsy being for diagnostic purposes. The four
patients who had had treatment (Had, Car, Gol
and Par) were those selected for the raising of anti-
idiotypic antibody. Treatment consisted of
intermittent radiotherapy and chemotherapy with
the biopsies being taken during disease
exacerbation. Serum samples for idiotype
measurements were taken approximately two
months post therapy. Patient Gol who presented
with lymph node disease subsequently developed a
leukaemia of the same clonal origin and culture
studies were carried out on these peripheral blood
cells. Material obtained from patients was placed
immediately in cold HEPES-buffered Eagle's
minimal essential medium (MEM, Flow
Laboratories, Inc., Walkersville, Md.) and brought
to the laboratory. Samples were sent for
histological analysis and the remainder used to
prepare a cell suspension as described previously
(Stevenson et al., 1980). Washed cells were
examined for surface or cytoplasmic Ig by
immunofluorescence and only those biopsies which
showed >60% involvement with monotypic B
cells, with few or no normal B cells and with no
significant intracellular Ig, were investigated
further. For culture, lymphocytes were suspended at
2 x 107ml-I in MEM containing 1% nonessential
amino acids, 2mM L-glutamine, 100 IUml- of
both penicillin and streptomycin, and 10% foetal
calf serum. Cells were swirled gently at 37°C, and
samples taken at intervals for assessment of Ig
production in the supernatants. The culture period
was usually 5-6h and cell viability was monitored
by Trypan Blue exclusion. For concentration of
culture fluids prior to molecular size determination,
an Amicon ultrafiltration apparatus with PM10
membrane was used (Amicon Corp., Scientific Sys.
Siv., Lexington, Mass.).
Measurement ofIg in cell culture
Samples of cell suspensions were removed at
intervals and, after centrifugation to remove cells,
the supernatant solutions were analyzed for Ig by
the enzyme-linked immunosorbent assay (ELISA)
(Engvall & Perlmann, 1972). Most of the anti-Ig
reagents used have been described previously
(Stevenson et al., 1980). They were all sheep anti-
bodies: sheep anti-K or sheep anti-) antibodies were
raised against K or A light chains and purified by
immunosorption; sheep anti-p chain antibody was
prepared by immunizing sheep with free p chains
and purifying the antibody by immunosorption on
a Sepharose 4B-CL column linked to normal
human IgM; sheep anti-Fdb was prepared by
immunizing sheep with Fabb obtained from normal
human IgD and absorbing the antibody with IgG,
this antibody was used as an IgG fraction; sheep
anti-y chain antibody was prepared by immunizing
sheep with free y chains and purifying the antibody
by immunosorption on a Sepharose 4B-CL column
linked to normal human IgG. All the antibodies
were assessed for specificity both by Ouchterlony
analysis and then in the ELISA test system.
Detecting antibodies for the ELISA were all
coupled to horse-radish peroxidase (HRP): for K
and A light chains, HRP-rabbit anti-human K chains
and HRP-rabbit anti-human A chains (Dako-
immunoglobulins a/s, Denmark) were absorbed
with normal sheep IgG to remove any interaction
between the sheep antibodies on the plate and
rabbit IgG; for IgM and IgG, HRP-goat anti-
human p chains and HRP-goat anti-human y chains
(Sigma Chemical Co. Ltd., Poole, Dorset) were
used respectively, with no extra absorption being
necessary; for IgD, a sample of the sheep anti-
human Fdb used for coating the plates was coupled
to horse-radish peroxidase (Sigma) by
glutaraldehyde.
For assessment of idiotypic Ig, sheep anti-
idiotypic antibodies were used: the method for
preparing these polyclonal antibodies has been
described in detail (Stevenson et al., 1983). Briefly,
tumour-related Faby was generated by papain
digestion of tumour cells lysed in dilute NP-40. The
Faby product was isolated on an immunosorbent
column and was used as a nucleus to build up more
immune complexes by passing sheep anti-human
IgM through the washed column. After further
washing, Faby and the attached antibodies were
eluted with 0.5M NH3, 1.OM KSCN and
immediately transferred back to neutral buffer by
passage through Sephadex G-25. Immunization of
sheep with the immune complexes was done as
described previously (Stevenson et al., 1983) and
the IgG fraction of the antiserum prepared.
Antibody activity against the constant regions of
the Faby was removed by a 2-stage
immunosorption using first a column consisting of
an IgM paraprotein of the same light chain class as
the tumour cells, linked to Sepharose 4B, followed
by a column consisting of human serum globulins
linked to Sepharose 4B.
Specificity of the absorbed antibody was tested
against cell targets and also by the ELISA
technique. For cell reactivity, fluorescent conjugates
of the antibodies were prepared (Nairn, 1976) and
tested by direct immunofluorescence. Each
fluorescent antibody was tested against homologous
tumour cells and also against tumour cells from the
other three patients. Each of the antibodies was
specific for the homologous tumour cells and
showed no reactivity with the other three cell
populations. The ELISA technique provides a
method which is an uptake assay and therefore
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idiotypic antibodies were bound to the plates at 25-
50 ugml-1 and binding tests were made using
normal human IgM and IgM paraproteins of the
same light chain class as the immunogen: in the
investigation of idiotypic IgM in serum, normal
human serum and the other three patients' sera
were used as controls. If any binding was observed
the antibody preparation was taken through the
absorption procedure again and retested.
Interference by normal human serum IgM was
accepted at <0.5%.
The ELISA test was carried out as described
previously (Tutt et al., 1983) by coating the wells of
a microtitre plate with 200 u1 of antibody in
carbonate buffer, pH9.5. Coating was for 1 h at
37°C followed by overnight at 4°C. Wells were then
treated with PBS-i% BSA for 1 h at 37°C followed
by washing with PBS-0.1% Tween 20. Solutions for
analysis were then placed in the wells and exposed
to bound antibody for 1 h at 37°C. After washing,
the enzyme-labelled antibody was added, incubated
for 1 h at 37°C and the plates then washed further.
Substrate (ortho-phenylene diamine) in a
phosphate-citrate buffer at pH 5.0 was then used to
generate colour which was measured in a
Microelisa Autoreader (Dynatech Laboratories Inc.,
Alexandria, Virginia 22314). Optimal
concentrations of coating and detecting antibodies
were determined by preliminary assays using
purified Ig preparations.
Results
Histology and surface Ig
The patients were divided into five groups (I-V) on
the basis of the lymph node biopsy (Table I).
Classification was that used by the Kiel group
(Gerard-Marchant et al., 1974) but in its simplest
form with the lymphomas of follicular centre cell
origin being divided only into nodular, where nodal
structure was clearly visible, or diffuse. The cells
involved in the nodular lymphomas were mixtures
of centroblasts and centrocytes with the latter
forming not less than 70% of the population. The
diffuse lymphomas were more heterogeneous, with
four being composed predominantly of centrocytes,
one predominantly of centroblasts, and one a
mixture of both (Table I). The other large group
was that of lymphocytic lymphoma consisting of
small lymphocytes of the CLL type, and there was
one patient described as an immunoblastic
lymphoma. One patient (group V) with a lymph
node showing cells of lymphoplasmacytoid
morphology has been included only for comparison
and is discussed separately. All the cell populations
expressed Ig of one light chain type.
Secreted Ig
The amounts of free light chain, IgM, IgD or IgG
found in the supernatant fluids after cell culture are
also shown in Table I. The units used are
moleculescell-1h- I x 10-1: time courses were
monitored to indicate true secretion as described
previously (Stevenson et al., 1980) and cell
viabilities were always >90% at the end of the
culture period of -6h. The sensitivity of the assays
means that for light chain estimation levels of <30
molecules of dimercell-1h- x 10-1 were
considered negative; the limits for IgM and IgG
were <30 molecules of monomercell- I h-1 x 10- I
and for IgD A18 molecules of
monomercell-1h-1 x 10 The small contribution
of the light chain in whole Ig to the light chain
assay (0.6 x the calculated amount of light chain in
combination) has been subtracted to give free light
chain production.
The first point is that 23/24 of the neoplastic
populations secreted free light chains which were
monotypic and of the same type as the surface Ig
light chain. Amounts secreted were quite variable
ranging from 150-3300 molecules of
dimercell-'h-1 x 10-1. Secretion of IgM was seen
in 17/24 of the cell populations with amounts
ranging from 39-2500 molecules of monomeric
IgMcell-1h- 1 x 10-1. IgD was found less
frequently with 6/21 secreting significant amounts,
four of these being of the A type: levels ranged from
21-130 molecules of monomeric
IgDcell h x 10-1. Three of 21 cell populations
appeared to secrete IgG, two of these also
expressing IgG at the cell surface: amounts ranged
from 40-157 molecules of monomeric
IgGcell-lh-I x 10-1.
The single patient in group V (Table I) with
neoplastic cells of lymphoplasmacytoid morphology
has been included to represent secretion rates of a
more mature cell type. In this case the level of
secretion was high (14,000
moleculescell -1h h- x 10-1) and a combination of
this and fairly extensive disease involving lymph
nodes, blood and bone marrow has led to the
presence of detectable IgM paraprotein in the
serum.
For the four patients for whom anti-idiotypic
antibody has been raised, the ELISA assay was
used to demonstrate the idiotypic nature of the
secreted Ig (Table II). A double-determinant assay
was used by coating the plates with anti-idiotype
and detecting the bound Ig using enzyme-labelled
anti-M or anti-6 (see Methods). The amount of
idiotypic IgM was measured in terms of the colour
produced by a standard curve of normal human
IgM bound to the plate by sheep anti-Fdp. In both
cases the detecting antibody was enzyme-labelled
anti-p. A similar procedure was used to measure582 F.K. STEVENSON et al.
Table I Secretion of Ig by cells obtained from patients with non-Hodgkin's lymphoma
Ig in culturefluidsa
% (moleculescell-1h-' x 10-1)
Surface Ig Neoplastic
Histologyb Patient isotypesc lymphocytes K A IgM IgD IgG
Row MDk+ 90 150 0 0 ND 0
Mat MDk+ 95 160 0 69 0 0
Col MDA+ 70 0 1130 78 0 0
I Lymphocytic Bro MDA+ 97 0 1280 99 21 ND
lymphoma Lan MDA+ 90 0 1920 0 33 0
Gin MDk+ + 74 163 0 42 0 0
Bai M(D)2+ + 80 0 920 420 130 ND
McW MGk+ 85 3350 0 770 0 114
The Mk+ 60 157 0 0 0 0
Hut MDk+ 80 600 0 0 0 0
All MDi+ + 77 0 0 0 0 0
Gol MA+ + 95 0 330 39 0 0
Tub MA+ + 80 0 247 90 0 0
Par Mk++ 80 512 0 244 0 0
Sin Mk+ + 95 211 0 142 25 0
Mor Dk+ + 90 274 0 0 0 0
Had M(G)k+ + 70 289 0 334 0 0
lymphoma CB-CC Hib Mk+ 91 509 0 139 0 0
CC Car MA+ 80 0 3160 163 27 0
III Diffuse CC Gen M(D)A+ + 75 0 834 60 0 0 CC Sta MD2+ + 80 0 1430 0 0 0
CB Win Mk+ + 90 1790 0 2500 36 0
CC Tho MGk+ 86 160 0 536 0 157
IV Immunoblastic Sta MG1+ 85 0 3300 60 0 ND
lymphoma
V Lymphoplasmacytic Hum Mk+ 70 0 0 14000 ND ND
lymphoma
'k and light chains are reported as free dimeric moleculescell-Ih- x 10-1. IgM, IgD and IgG are reported
as monomeric moleculescell - I h - 1 x 10- .
bHistological classification was based on that of the Kiel group (Gerard-Marchant et al., 1974) where CB and
CC refer to cells of the follicle centre, centroblasts and centrocytes respectively, with CB-CC indicating a
mixture of the two cell types.
'Surface Ig was detected by immunofluorescence: levels of fluorescence are indicated by plus marks, and where
an individual heavy chain class is of low fluorescence it is in parenthesis.
dFollicular centre cell lymphoma.
Table II Reactivity of Ig from culture fluids with anti-idiotypic
antibodies
Ig levels in culturefluidsa
(moleculescell-'h-' x 10-1)
Total Idiotypic % Total Idiotypic %
Patient IgM IgM Idiotype IgD IgD Idiotype
Had 333 312 >90 0 0
Car 162 156 >90 27 18 70
Gol 39 54 >90 0 0
Par 243 246 >90 0 0
alg levels in culture fluids were measured by the ELISA technique.
Anti-idiotypic antibody from each patient did not bind Ig from culture
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idiotypic IgD with normal IgD being bound to the
plate by sheep anti-Fdb and detecting antibody
enzyme-labelled anti-5. Where isolated idiotypic
IgM has been available (Stevenson et al., 1980) the
colour yields obtained by binding to plates via anti-
idiotype or via anti-Fdy and detecting with enzyme-
labelled anti-p have been equivalent. The ELISA
technique also demonstrated specificity of the anti-
idiotypes since cultures from the other three
patients showed no reactivity with the fourth anti-
idiotypic antibody. In the case of patient Car, it
was shown that the secreted IgD was of the same
idiotype as the IgM.
To demonstrate the molecular size of the secreted
IgM, culture fluids from three patients, Bro, Had
and Win, selected at random from each of the three
major histological groups, were concentrated x 10
and 1 ml aliquots applied to a column of Ultrogel
AcA 22 as described previously (Stevenson et al.,
1980). The ELISA assay was used on column
effluents to compare the mobility of the secreted
IgM with that of a pentameric IgM standard. In all
three cases, a single major peak of IgM was
detected coincident with the position of pentameric
IgM (data not shown).
Idiotypic Ig in serum
Where anti-idiotypic antibody was available
(patients Had, Car, Gol and Par) it was possible to
examine the patients' sera for the presence of the Ig
shown to be secreted in vitro. The double-
determinant ELISA assay was used again, with
pooled normal human serum at the same dilution
as a control in all cases to ensure specificity of the
anti-idiotypic antibodies. Any free light chain in the
serum would not be detected by this double-
determinant assay, but previous studies on patients
with CLL have shown that such light chain is
rapidly cleared from the serum and can be detected
in the urine; also anti-idiotypic antibody raised
against heavy plus light chain idiotypes does not
appear to recognise free light chain, rendering it of
less importance in this study (Tutt et al., 1983).
Results are shown in Table III: all four patients
had idiotypic IgM in the serum and in the case of
patient Car both idiotypic IgM and IgD were
present as predicted from the results in vitro. More
recently using a mouse monoclonal anti-idiotypic
antibody raised against the surface IgM of patient
ALL (Table I) (kindly provided by Dr M.G.
Glennie) and a similar double-determinant ELISA
assay, it has been possible to show that there is no
idiotypic IgM in the serum of this patient. The
molecular size of the serum idiotypic IgM was
investigated for two of the patients (Car and Gol)
by separation of 1 ml of serum on Ultrogel AcA 22
in the same way as for the culture fluids and was
again shown to be pentameric.
Measurements of idiotypic IgM in the serum of
patient Gol were made over a 38 week period
during which treatment with two different drug
combinations was carried out. Patient Gol, as
described in Methods, presented with lymph node
disease but later developed a leukaemia: the pattern
of disease became one of increasing anaemia as
tumour cells appeared in the bone marrow followed
by a rapid increase in circulating tumour cells and
clinical relapse. Such an episode is shown in Figure
1 where treatment with a drug combination of
adriamycin, 6-thioguanine and cytosine arabinoside
although producing an apparent clinical remission
was followed -10 weeks later by recurrent lymph
node and spleen enlargement together with
developing anaemia. By week 28 the patient had a
high blood lymphocyte count and was given
chlorambucil and prednisolone which brought
about a dramatic response with a fall in circulating
tumour cells and clinical improvement. The
idiotype levels measured during this period are also
Table III Idiotypic Ig in patients' sera
Ig levels in serum'
(gml-1)
Total Idiotypic % Total Idiotypic %
Patient IgM IgM Idiotype IgD IgD Idiotype
Had 390 24 6 10.2 0
Car 92 4 4 7.0 3.5 50
Gol 434 35 8 6.6 0
Par 185 4 2 6.3 0
aSerum samples were obtained from the patients -2 months after
cessation of chemotherapy (Had, Gol and Par) or radiotherapy (Car).
Ig levels were measured by the ELISIA technique. Anti-idiotypic
antibody prepared for each patient was tested with normal human
serum IgM and interference was <0.5%.584 F.K. STEVENSON et al.
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Figure 1 Levels of idiotypic IgM in the serum of patient Gol during two treatments with chemotherapy.
(O), blood lymphocyte count (x 10-91-1); vertical lines, idiotype IgM (pgml-' serum). Treatment
consisted ofA, adriamycin, 6-thioguanine and cytosine arabinoside; B, chlorambucil and prednisolone.
indicated in Figure 1 where it can be seen that there
was no fall during the first rather ineffective
treatment and that levels were rising in the serum
some weeks before any tumour cells could be seen.
After the second treatment, idiotype levels fell
dramatically as the patient improved clinically.
Discussion
Patterns of secretion of Ig by unstimulated
neoplastic B lymphocytes from patients with CLL
have been studied previously and it has been shown
that then.majority (13/19 patients) do secrete small
amounts of pentameric IgM which can be found in
the patient's serum (Stevenson et al., 1980). These
low levels of secretion have been confirmed by
others (Johnstone et al., 1982) and the presence of
intracellular IgM in cells from such patients has
been detected by using sensitive immunoelectron
microscopy (Yasuda et al., 1982). Secretion of free
monotypic light chain by the majority of CLL cell
populations has also been observed (Hannam-
Harris et al., 1980). A smaller proportion of such
cell populations (8/19) all of which had surface Ig
of the A light chain type, secreted monomeric IgD
(Stevenson et al., 1982).
Studies on the secretory capacity of neoplastic B
lymphocytes have now been extended to patients
with NHL for two main reasons: first, to
investigate whether such cells have different
patterns of secretion which might relate to the stage
of differentiation at which arrest has occurred; and
second, to examine secretory capacity in relation to
production of soluble idiotypic Ig which would
block an immunotherapeutic attack on the tumour
cells by anti-idiotype. Conversely the serum
idiotypic Ig should provide a useful tumour marker
for monitoring disease levels.
Comparison of the data obtained on culturing
monotypic lymph node cells from patients with
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blood lymphocytes in CLL reveals that there are no
major differences between the two diseases. Thus in
CLL 19/19 secreted monotypic light chain and
13/19 secreted IgM (Stevenson et al., 1982); in
NHL 23/24 secreted light chain and 17/241gM. For
IgD, in CLL 8/19 were positive whereas in NHL
6/21 were positive. Levels of secretion showed that
CLL cells tended to secrete more free light chain
(1620+860) than NHL (1000+1050) and less IgM
(170+93) than NHL (340+600), all units being
moleculescell- 1h- I x 10-1, and given as
mean+SD but larger groups would have to be
studied to assess the significance of the differences
due to the heterogeneity in amounts secreted. A
previous study of secretory patterns of cells from
patients with NHL was carried out in this
laboratory using the less direct technique of
biosynthetic radiolabelling (Hannam-Harris et al.,
1982). Although it was more difficult to analyse the
nature and amount of whole Ig secretion by this
method, the measurement of light chain:heavy
chain ratios showed a similar heterogeneous
pattern.
Among the 24 cell populations from patients with
NHL showing surface Ig of different classes and
intensities there was no clear trend relating
secretory capacity to surface Ig expression.
Secretion of IgG was found in only three cell
populations and further work is required to
establish the clonal origin of this IgG.
The molecular size of the IgM in culture fluids
was examined for three patients and was shown to
be consistent with that of pentameric IgM. A
similar finding was made for CLL cultures
(Stevenson et al., 1980) and indicates that the
pathway of production is secretion rather than
membrane "shedding". Surface labelling with
lactoperoxidase was used previously to show that
membrane Ig, if shed in the medium, is in a high
molecular weight, probably vesicular form which
does not enter the sizing column. The normal fate
of surface IgM may well be via internalisation as
has been suggested for other plasma membrane
components (Doyle & Baumann, 1979).
The clonal origin of the secreted Ig has been
demonstrated for four of the lymphoma patients
for whom anti-idiotypic antibody was available.
The idiotypic Ig was detectable in the serum of
these patients although the percentage of the total
serum IgM which was idiotypic (2-8%) was lower
than that observed previously in CLL (57-93%),
possibly reflecting different disease loads and
complicated in these four patients by previous
therapy. Correlation between the ability of cells to
secrete idiotypic Ig in vitro and the measured level
in serum cannot be examined without accurate
assessment of disease load which is difficult to
make. However, preliminary investigation of patient
ALL whose cells secrete no Ig in culture has shown
no idiotypic Ig to be present in the serum, making
this patient a prime candiate for therapy with anti-
idiotype. At the other end of the scale, the patient
with a detectable IgM paraprotein in the serum had
neoplastic cells which secreted IgM at a rate
approximately forty times the average value for the
24 lymph node biopsies studied.
Idiotypic levels may be particularly useful for
longitudinal studies on individual patients. The
results on patient Gol showing a rise in serum
idiotypic IgM occurring before any clear clinical
changes followed by a fall post-chemotherapy
indicate a good correlation with disease. As regards
immunotherapy with anti-idiotype, which may have
some promise in lymphoma (Hamblin et al., 1980;
Miller et al., 1982), however, any circulating
idiotype presents a problem which is only partly
solved by plasmapheresis (Hamblin et al., 1980).
Culture of a small aliquot of a patient's tumour
cells in vitro with measurement of secreted IgM
should help predict suitable cases for treatment: this
is now done as a routine in this laboratory before
embarking on the raising of anti-idiotypic antibody.
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